Patent Assignment
Reel/Frame 027280/0954
Security Agreement
Recorded: 2011-11-23
Pages: 8
Assignor
KADMON PHARMACEUTICALS, LLC
Executed: 2011-10-31
Assignee
CORTLAND CAPITAL MARKET SERVICES LLC, AS ADMINISTRATIVE AGENT
225 W. WASHINGTON STREET, SUITE 1450, CHICAGO, ILLINOIS, 60606
Covered Properties
(29)
Microbial Production of Mature Human Leukocyte Interferons
Patent:
6,610,830 →
Application:
06/256,204 →
Consensus Human Leu Kocyte Interferon
Patent:
4,695,623 →
Application:
06/560,495 →
Consensus Human Leukocyte Interferon
Patent:
4,897,471 →
Application:
07/099,096 →
Microbial Production of Mature Human Leukocyte Interferons
Patent:
6,482,613 →
Application:
07/145,002 →
Consensus Human Leukocyte Interferon
Patent:
5,541,293 →
Application:
07/472,328 →
Methods and Compositions for the Treatment of Diseases with Consensus Interferon While Reducing Side Effect
Patent:
5,372,808 →
Application:
07/868,916 →
N-Terminally Chemically Modified Protein Compositions and Methods
Patent:
5,824,784 →
Application:
08/321,510 →
Methods for Retreatment of Patients Afflicted with Hepatitis C Using Consensus Interferon
Patent:
5,980,884 →
Application:
08/595,440 →
Recombinant Production of Consensus Human Leukocyte Interferon
Patent:
5,661,009 →
Application:
08/686,822 →
Use of the Human Interferon Consensus Gene for Gene Therapy
Patent:
5,831,062 →
Application:
08/852,889 →
N-Terminally Chemically Modified Protein Compositions and Methods
Patent:
5,985,265 →
Application:
08/879,760 →
Treatment of Multiple Sclerosis Using Consensus Interferon and Il-1 Receptor Antagonist
Patent:
6,013,253 →
Application:
08/911,893 →
Process for Producing Wet Ribavirin Pellets
Method for treating hepatitis c virus infection in treatment failure patients
Application:
10/490,456 →
Publication:
US 2005/0031585
Method of treating hepatitis virus infection with a multiphasic interferon delivery profile
Application:
10/490,458 →
Publication:
US 2005/0063949
Method for treating hepatitis c virus infection in treatment failure patients
Application:
10/490,503 →
Publication:
US 2005/0031586
Combination therapy for treating alphavirus infection and liver fibrosis
Application:
10/545,864 →
Publication:
US 2007/0072181
Continuous delivery methods for treating hepatitis virus infection
Application:
10/545,867 →
Publication:
US 2007/0077225
Compositions and methods for treating poxvirus infection
Application:
10/551,368 →
Publication:
US 2007/0154454
Combination Therapy for Treating Hepatitis C Virus Infection
Application:
10/584,169 →
Publication:
US 2007/0258946
Composition containing ribavirin and use thereof
Application:
10/665,728 →
Publication:
US 2004/0258751
Process for producing wet ribavirin pellets
Application:
10/765,134 →
Publication:
US 2005/0075297
Compositions and methods for treating coronavirus infection and SARS
Application:
10/814,701 →
Publication:
US 2005/0002901
Composition Containing Ribavirin and Use Thereof
Large Dose Ribavirin Formulations
Large Dose Ribavirin Formulations
Application:
11/693,993 →
Publication:
US 2007/0161583
Large Dose Ribavrin Formulatons
Application:
12/180,139 →
Publication:
US 2009/0012015
Continuous Delivery Methods for Treating Hepatitis Virus Infection
Application:
12/420,459 →
Publication:
US 2009/0226400
Large Dose Ribavirin Formulations
Application:
12/761,869 →
Publication:
US 2010/0203127
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Apr 21, 1981
From: GOEDDEL DAVID V.
To: GENENTECH, INC., A CORP. OF CA
Reel/Frame 003881/0454 →
Assignment of Assignors Interest.
Jun 12, 1981
From: PESTKA SIDNEY
To: HOFFMANN-LA ROCHE INC., A CORP. OF NJ
Reel/Frame 003869/0834 →
Assignment of Assignors Interest.
Jan 27, 1984
From: ALTON, NORMAN K.; PETERS, MARY A.; STABINSKY, YITZHAK; SNITMAN, DAVID L.
To: AMGEN
Reel/Frame 004213/0954 →
Assignment of Assignors Interest.
Dec 13, 1991
From: AMGEN A CORP. OF CALIFORNIA
To: AMGEN INC. A CORP. OF CALIFORNIA
Reel/Frame 005945/0295 →
Assignment of Assignors Interest.
Jun 22, 1992
From: BLATT, LAWRENCE M.; TAYLOR, MILTON W.
To: AMGEN INC.
Reel/Frame 006199/0142 →
Assignment of Assignor's Interest
Feb 1, 1995
From: KINSTLER, OLAF B.; GABRIEL, NANCY E.; FARRAR, CHRISTINE E.; DEPRINCE, RANDOLPH B.
To: AMGEN INC.
Reel/Frame 007321/0265 →
Assignment of Assignor's Interest
Feb 2, 1996
From: BLATT, LARRY; KLEIN, MICHAEL
To: AMGEN INC.
Reel/Frame 007867/0500 →
Assignment of Assignor's Interest
Jun 23, 1997
From: TAYLOR, MILTON W.; BLATT, LAWRENCE M.
To: AMGEN INC.
Reel/Frame 008680/0781 →
Assignment of Assignor's Interest
Aug 15, 1997
From: MARTIN, DAVID; FISCHER, NORMAN L.
To: AMGEN INC.
Reel/Frame 008749/0006 →
Assignment of Assignor's Interest
Aug 18, 1997
From: STABINSKY, YITZHAK
To: AMGEN INC., A DELAWARE CORPORATION
Reel/Frame 008669/0351 →
Assignment of Assignor's Interest
Mar 19, 2001
From: KERRISH, DONALD J.; BERGERON, JOHN R.; AUGSBURGER, LARRY L.
To: THREE RIVERS PHARMACEUTICAL, LLC
Reel/Frame 011949/0712 →
Re-Record to Correct the Assignee, Previously Recorded at Reel 011949, Frame 0712.
Sep 25, 2001
From: KERRISH, DONALD J.; BERGERON, JOHN R.; AUGSBURGER, LARRY L.
To: THREE RIVERS PHARMACEUTICAL, LLC
Reel/Frame 012198/0613 →
Assignment of Assignor's Interest
Jun 3, 2004
From: KERRISH, DONALD J.; BERGERON, JOHN R.; AUGSBURGER, LARRY L.
To: THREE RIVERS PHARMACEUTICALS, LLC
Reel/Frame 015411/0895 →
Assignment of Assignor's Interest
Jul 2, 2004
From: KERRISH, DONALD J.; BERGERON, JOHN R.; AUGSBURGER, LARRY L.
To: THREE RIVERS PHARMACEUTICALS, LLC
Reel/Frame 015545/0340 →
Assignment of Assignor's Interest
Aug 20, 2004
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 015920/0814 →
Assignment of Assignor's Interest
Aug 20, 2004
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 015920/0904 →
Assignment of Assignor's Interest
Aug 20, 2004
From: BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 015016/0630 →
Assignment of Assignor's Interest
Sep 30, 2004
From: VISOR, GARY; VAN VLASSELAER, PETER
To: INTERMUNE, INC.
Reel/Frame 016040/0597 →
Corrective Assignment to Correct the Filing Date of Application Number 10490456 Previously Recorded on Reel 015920 Frame 0904. Assignor(S) Hereby Confirms the Correct Filing Date Is 08/20/2004.
Jul 20, 2005
From: HSU, HENRY H.
To: INTERMUNE, INC.
Reel/Frame 016287/0579 →
Assignment of Assignor's Interest
Feb 1, 2006
From: INTERMUNE, INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 017224/0910 →
Assignment of Assignor's Interest
Jun 12, 2006
From: BLATT, LAWRENCE M.; MURPHY, BRIAN M.
To: INTERMUNE, INC.
Reel/Frame 017764/0276 →
Assignment of Assignor's Interest
Dec 6, 2006
From: INTERMUNE INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 018614/0270 →
Assignment of Assignor's Interest
Dec 6, 2006
From: INTERMUNE INC.
To: VALEANT PHARMACEUTICALS NORTH AMERICA
Reel/Frame 018608/0846 →
Assignment of Assignor's Interest
Jun 4, 2007
From: BLATT, LAWRENCE M.
To: INTERMUNE, INC.
Reel/Frame 019373/0588 →
Assignment of Assignor's Interest
Jan 7, 2008
From: KERRISH, DONALD J.; BERGERON, JOHN R.; AUGSBURGER, LARRY L.
To: THREE RIVERS PHARMACEUTICAL, LLC
Reel/Frame 020347/0358 →